Dow Inc vs GeneDx Holdings Corp — how do they compare? Dow Inc trades at $30.63 (market cap $22.58B), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: Dow Inc is far larger — about 9.3× GeneDx Holdings Corp's market cap, and Dow Inc pays a 4.48% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| DOW | WGS | |
|---|---|---|
Market Cap | $22.58B | $2.44B |
Sector | Basic Materials | Technology |
52-Week High | $41.87 | $167.51 |
52-Week Low | $20.65 | $34.51 |
Enterprise Value | $38.27B | $2.48B |
Dividend Yield | 4.48% | — |
Signals from Pluang's Aura AI — not financial advice
DOW trades at $30.64, up 0.2% with a bullish technical signal and recent earnings beats. The company shows declining revenue trends from $56.9B in 2022 to $40.0B in 2025, with negative net income margins. Analyst consensus is mixed with 33% buy ratings and a $35.11 price target, representing 15% upside. Recent dividend payment of $0.35 provides income support amid challenging fundamentals.
While technical indicators suggest near-term strength, fundamental challenges persist with negative profitability and declining cash flow. The stock offers potential upside to analyst targets but faces execution risks in a competitive chemical sector. Dividend yield provides some cushion, but investors need sustained operational improvement for meaningful long-term returns.
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
Trailing returns across standard periods
Latest headlines on both assets
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →